orphenadrine has been researched along with flupenthixol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartlett, W; Bourne, RC; Cotes, PM; Crow, TJ; Johnstone, EC | 1 |
Crome, P | 1 |
Johnson, DA | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
1 review(s) available for orphenadrine and flupenthixol
Article | Year |
---|---|
Antidepressant overdosage.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Brompheniramine; Flupenthixol; Humans; Iprindole; Lithium; Mianserin; Monoamine Oxidase Inhibitors; Nomifensine; Orphenadrine; Parasympatholytics; Pyridoxine; Trazodone; Tryptophan; Viloxazine; Zimeldine | 1982 |
2 trial(s) available for orphenadrine and flupenthixol
Article | Year |
---|---|
Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication.
Topics: Acute Disease; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Flupenthixol; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Orphenadrine; Prolactin; Receptors, Dopamine; Schizophrenia; Testosterone; Thioxanthenes | 1978 |
Studies of depressive symptoms in schizophrenia.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Flupenthixol; Fluphenazine; Humans; Longitudinal Studies; Male; Middle Aged; Nortriptyline; Orphenadrine; Schizophrenia; Schizophrenic Psychology | 1981 |
1 other study(ies) available for orphenadrine and flupenthixol
Article | Year |
---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |